Back to Authors

García‐Sastre, Adolfo

https://orcid.org/0000-0002-6551-1827

Mayo Clinic

Tisch Cancer Institute

Citations 2

Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
Nace, Rebecca A., Zhang, Lianwen , Singh, Gagandeep , Warang, Prajakta , Narjari, Riya , Vandergaast, Rianna , Peng, Kah-Whye , Schotsaert, Michael , Muñoz-Alía, Miguel Á , Packiriswamy, Nandakumar, Vandergaast, Rianna , Peng, Kah-Whye , García-Sastre, Adolfo , Muñoz-Alía, Miguel Ángel , Balakrishnan, Baskar , Packiriswamy, Nandakumar , Mena, Ignacio , García‐Sastre, Adolfo

mBio | January 9, 2024 | Volume: 15 | Issue: 2 | Pages: No page available

10.1128/mbio.02928-23 Get It

Although the live-attenuated measles virus (MeV) is one of the safest and most efficacious human vaccines, a measles-vectored COVID-19 vaccine candidate expressing the SARS-CoV-2 spike failed to elicit neutralizing antibody (nAb) responses in a phase-1 clinical trial, especially in measles-immune individuals. Here, we constructed a comprehensive panel of MeV-based COVID-19 vaccine candidates using a MeV with extensive modifications on the envelope glycoproteins (MeV-MR). We show that artificial trimerization of the spike is critical for the induction of nAbs and that their magnitude can be significantly augmented when the spike protein is synchronously fused to a dodecahedral scaffold. Furthermore, preexisting measles immunity did not abolish heterologous immunity elicited by our vector. Our results highlight the importance of antigen optimization in the development of spike-based COVID-19 vaccines and therapies.
Turkey Versus Guinea Pig Red Blood Cells: Hemagglutination Differences Alter Hemagglutination Inhibition Responses Against Influenza A/H1N1
Ovsyannikova, Inna G. , White, Sarah J., Albrecht, Randy A. , García‐Sastre, Adolfo , Poland, Gregory A. , García-Sastre, Adolfo

Viral Immunology | April 30, 2014 | Volume: 27 | Issue: 4 | Pages: 174-178

10.1089/vim.2013.0111 Get It

For influenza hemagglutination inhibition (HAI) assays, species selection of red blood cells (RBCs) is critical to determine antibody titers to influenza viruses reliably. We compared pandemic influenza virus A/H1N1 (pdH1N1) HAI titers using turkey or guinea pig RBCs. Turkey RBCs appear to be the more appropriate species choice for influenza A/pH1N1 HAI assays.